Tag: License Agreement

May 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent

Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018

MicroVision, Inc. Announces New License Agreement with a Leading Technology Company

MicroVision Inc (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and sensing technology announced that it entered into a license...
May 10, 2018

Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan

Aquinox Pharmaceuticals (NASDAQ:AQXP) a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood...
May 4, 2018
May 2, 2018

Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the U.S. Patent and Trademark Office ("USPTO") issued...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 27, 2018
April 26, 2018

INDIVA Granted Exclusive Rights to DeepCell™ Industries’ Products in Canada

INDIVA Limited (TSXV:NDVA) (the "Company" or "INDIVA") is pleased to announce an exclusive license agreement with, and a USD $1.5...
April 25, 2018

Daré Bioscience and Juniper Pharmaceuticals Enter Global License Agreement

In early trading on Wednesday, Daré’s share price increased nearly 73 percent before leveling at a 56.69-percent increase.